Our results showed that low expressions of Beclin 1 and LC3B were correlated with metastasis in colorectal cancer, suggesting Beclin 1 and LC3B contributed to the development of metastatic CRC. This evidence concerns the gene MAP1LC3B and colorectal cancer.